The first category included biopharmaceuticals, complex generic drugs, patented drugs or drugs nearing patent expiry, cell-based or gene therapy drugs, orphan drugs, special empty capsules like HPMC, pullulan, enteric etc., complex excipients, and phytopharmaceuticals.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3p2U3DV
via IFTTT
0 comments:
Post a Comment